Orvida Pharma Ltd.
PrivateLast Round
VC Round
Sep 15, 2026
Total Funding Raised
$23M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Orvida Pharma Ltd. is a biotechnology company that develops disease-modifying therapies for rare and severe genetic skin diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orvida Pharma Ltd. Comparables
Compare Orvida Pharma Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quoin Pharmaceuticals | 78% | |
| Patagonia Pharmaceuticals, LLC | 77% | |
| Azitra, Inc. | 69% |
Orvida Pharma Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 15, 2026 | ||||
| Series A | Jun 3, 2025 | ||||
| VC Round | Sep 19, 2022 |
Orvida Pharma Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pontifax Venture Capital | VC Round, Series A |
| BRM Group | Series A |
| Guangzhou Sino-Israel Bio-Industry Investment Fund | VC Round |
| Arkin Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 15, 2026
Recordati SpA led the VC Round fundraise.
- May 19, 2026
Monthly visitors increased 798% MoM.
Recent news
Latest coverage and updates
- attends_eventSep 15, 2026
Orvida Pharma is scheduled to participate in the Jefferies Global Healthcare Conference in United Kingdom on Nov 16th–19th '26 and is available for one-on-one meetings with investors and pharmaceutical companies.
- attends_eventSep 15, 2026
Orvida Pharma delivers a corporate presentation and is available for one-on-one meetings with investors and pharma companies during BIO-Europe 2026 in Germany on Nov 9th-11th '26.
Orvida Pharma Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Orvida Pharma Ltd.'s valuation, stock price, and market status.
Is Orvida Pharma Ltd. a public or private company?
Orvida Pharma Ltd. is a private company.
What is the current stock price of Orvida Pharma Ltd.?
Orvida Pharma Ltd. is a private company, so its shares have no public market price. Caplight tracks Orvida Pharma Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Orvida Pharma Ltd. worth (valuation)?
Valuation information for Orvida Pharma Ltd. is not publicly available.
Can I buy Orvida Pharma Ltd. stock?
Orvida Pharma Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Orvida Pharma Ltd.'s last funding round?
Orvida Pharma Ltd.'s most recent funding round was VC Round on September 15, 2026.
Who are the main investors in Orvida Pharma Ltd.?
Key investors in Orvida Pharma Ltd. include Pontifax Venture Capital, BRM Group.
Will Orvida Pharma Ltd. IPO soon?
No public IPO plans have been announced for Orvida Pharma Ltd..
How can I track Orvida Pharma Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Orvida Pharma Ltd.'s shares on secondary markets.